A consortium led by Ardian, the France based investment firm, has agreed to acquire an additional 19% stake in Dedalus, the Italy based developer of healthcare softwares, from founder Giorgio Moretti. Subject to customary authorizations by the competent authorities, upon completion of the transaction, the consortium led by Ardian will indirectly hold a 92% stake in the Company, with Moretti retaining a 6% stake and a seat in the board.
Target – Dedalus S.P.A
Buyer – Ardian
Buyer – Other Undisclosed investors
Seller – Giorgio Moretti (private investor)